Kaplan-Meier curve showing the relapse-free survival for all 80 patients achieving remission from HIV-associated MCD following rituximab-based first-line therapy. In this analysis, the development of HHV8-associated lymphoma is taken as a relapse even if the biopsy did not include the presence of MCD.